In modern surgical procedures sealants and adhesives have become useful accompaniments as they have evolved over the years. Their efficacy, usability in repairing injured tissues, safety and support for wounds obtained during surgery are the causes for their wide-scale adoption.
Asia Pacific Surgical Sealants and Adhesives Market size was almost USD 394 million in 2018. It is expected to grow at a CAGR of 9.8 % to reach USD 689 million by 2023. It is the fastest growing market capturing a 19% of the global market share.
Rising concerns to reduce surgical wounds along with growing demand for surgical services are the primary causes for market growth. Approximately 235 million major surgeries are carried out globally per year as per the WHO estimates which augurs well for the market. It is because surgical procedures are usually accompanied by risk of wound infection, tissue damage or excessive bleeding.
The limiting factors for market growth are high costs, cumbersome regulatory procedures and stringent rules of compliance.
Asia Pacific Surgical Sealants and Adhesives Market can be categorized into three categories: by product, by indication and by application. On the basis of product, Asia Pacific Surgical Sealants and Adhesives market is classified into Natural/Biological Sealants and Adhesives and Synthetic and Semi-Synthetic Sealants and Adhesives. Natural/Biological Sealants and Adhesives is further segmented into type and origin. By type it is categorized into Polypeptide/Protein-based Sealants and Adhesives (Fibrin-based Adhesives, Gelatine-based Adhesives, Collagen-based Adhesives and Albumin-based Adhesives) and Polysaccharide-based Sealants and Adhesives (Polysaccharide-based Sealants and Adhesives and Other Polysaccharide-based Adhesives). By Origin it sub-segmented into Human Blood-based and Animal-based. Further, Synthetic and Semi-Synthetic Sealants and Adhesives has been categorized into Cyanoacrylates, Polyethylene glycol Hydrogels, Urethane-based Adhesives and Other Synthetic Adhesives. In the polypeptide sealants and adhesives category, the fibrin-based adhesives commanded the largest market share because of the wide range of applications of these sealants in surgical areas for example, cardiac, spleen surgeries, liver, colonic anastomosis, and seroma prevention after soft tissue dissections.
Furthermore, the gelatine-based adhesives category is estimated to grow at the highest CAGR during the aforementioned forecast period because of their tensile strength, high elasticity and high-adhesive. Moreover, on the basis of indication, the market is segmented into Surgical Haemostasis, Tissue Sealing and Tissue Engineering. In addition, on the basis of application the market can be categorized into Central Nervous System (CNS) Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopaedic Surgeries, Cosmetic Surgeries, Urological Surgeries, Pulmonary Surgeries, Ophthalmic Surgeries and Other Applications.
By geography, the Asia Pacific Surgical Sealants and Adhesives market has been categorized into India, China, Korea, Japan and other countries. Presently, Asia Pacific has the highest CAGR. Creation of a sustainable health system because of the ongoing transformation of healthcare delivery systems into advanced value-based healthcare practices is the primary cause attributable to the observable trend mentioned above. This makes better facilities available at cheaper rates and promote the use of novel techniques in surgeries and other healthcare practices. Secondary factors include increasing medical tourism, growing per capita income, the presence of less stringent regulations and rise in investment by major players in this region.
CryoLife, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc., Baxter International, Inc. (U.S.), and C.R. Bard, Inc. (U.S.) held the key share of the surgical sealants and adhesives market and are likely continue to dominate the market between 2018 and 2023. Some of the primary players operating in this market are Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis Ltd. (Israel), Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Natural/Biological Sealants and Adhesives
5.1.2.1 Natural/Biological Sealants and Adhesives, By Type
5.1.2.1.1 Polypeptide/Protein-Based Sealants and Adhesives
5.1.2.1.1.1 Fibrin Based
5.1.2.1.1.2 Collagen Based
5.1.2.1.1.3 Gelatin Based
5.1.2.1.1.4 Albumin Based
5.1.2.1.2 Polysaccharide Based Sealants and Adhesives
5.1.2.1.2.1 Chitosan Based
5.1.2.1.2.2 Other Polysaccharide Based
5.1.2.2 Natural/Biological Sealants and Adhesives, By Origin
5.1.2.2.1 Human Blood Based
5.1.2.2.2 Animal Based
5.1.3 Synthetic and Semisynthetic Sealants and Adhesives
5.1.3.1 Cyanoacrylates
5.1.3.2 Polyethylene Gylcol Based Hydrogel
5.1.3.3 Urethane-Based Adhesives
5.1.3.4 Other Synthetic Sealants and Adhesives
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Indication
5.2.1 Introduction
5.2.2 Surgical Hemostasis
5.2.3 Tissue Sealing
5.2.4 Tissue Engineering
5.2.5 Y-o-Y Growth Analysis, By Indication
5.2.6 Market Attractiveness Analysis, By Indication
5.2.7 Market Share Analysis, By Indication
5.3 Application
5.3.1 Introduction
5.3.2 Central Nervous System (CNS) Surgeries
5.3.3 General Surgeries
5.3.4 Cardiovascular Surgeries
5.3.5 Orthopedic Surgeries
5.3.6 Cosmetic Surgeries
5.3.7 Ophthalmic Surgeries
5.3.8 Urological Surgeries
5.3.9 Pulmonary Surgeries
5.3.10 Other Applications
5.3.11 Y-o-Y Growth Analysis, By Application
5.3.12 Market Attractiveness Analysis, By Application
5.3.13 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Indication
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Indication
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Indication
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International, Inc. (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Johnson & Johnson (Ethicon, Inc.; U.S.)
8.3 CryoLife, Inc. (U.S.)
8.4 C. R. Bard
8.5 Aastrom Biosciences
8.6 Medtronic plc (U.S.)
8.7 Sanofi Group (France)
8.8 B. Braun Melsungen AG (Germany)
8.9 Cohera Medical
9.Competitive Landscape
9.1 Market share analysis
